Patent · US Active

Pharmaceutical composition, methods for treating and uses thereof

US12427162B2 · kind B2 · utility

0Cited by

79References

16Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Uli Christian BROEDL · Oakville, CA
Odd-Erik JOHANSEN · Måløy, NO
Eric Williams MAYOUX · Gambais, FR
Nima SOLEYMANLOU · Sherwood Park, CA
Maximilian von EYNATTEN · Wiesbaden, DE
Hans-Juergen WOERLE · Munich, DE
David Z.I. CHERNEY · Toronto, CA
Bruce A. PERKINS · Toronto, CA

Key dates

Filing date	Nov 21, 2023
Grant date	Sep 30, 2025
Priority date	—
Expiry date	Dec 27, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to certain SGLT-2 inhibitors for treating, preventing, protecting against and/or delaying the progression of chronic kidney disease in patients, for example patients with prediabetes, type 1 or type 2 diabetes mellitus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.